Head and neck cancer: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: ==Treatment== {{PDQ-treatment|http://www.cancer.gov/cancertopics/types/head-and-neck|Head and Neck Cancer}} {{PDQ-treatment|http://www.cancer.gov/cancertopics/pdq/treatment/salivarygland/...) |
imported>Robert Badgett No edit summary |
||
| Line 1: | Line 1: | ||
==Cause / etiology== | |||
[[Human papillomavirus]] (HPV) is a risk factor for oropharyngeal cancer.<ref name="pmid18784104">{{cite journal| author=Haddad RI, Shin DM| title=Recent advances in head and neck cancer. | journal=N Engl J Med | year= 2008 | volume= 359 | issue= 11 | pages= 1143-54 | pmid=18784104 | |||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=18784104 | doi=10.1056/NEJMra0707975 }} </ref> | |||
==Treatment== | ==Treatment== | ||
{{PDQ-treatment|http://www.cancer.gov/cancertopics/types/head-and-neck|Head and Neck Cancer}} | {{PDQ-treatment|http://www.cancer.gov/cancertopics/types/head-and-neck|Head and Neck Cancer}} | ||
{{PDQ-treatment|http://www.cancer.gov/cancertopics/pdq/treatment/salivarygland/HealthProfessional/page5|Salivary Gland Cancer}} | {{PDQ-treatment|http://www.cancer.gov/cancertopics/pdq/treatment/salivarygland/HealthProfessional/page5|Salivary Gland Cancer}} | ||
===Cetuximab=== | |||
[[Cetuximab]] may benefit cancers by inhibiting [[epidermal growth factor receptor]].<ref name="pmid18784104">{{cite journal| author=Haddad RI, Shin DM| title=Recent advances in head and neck cancer. | journal=N Engl J Med | year= 2008 | volume= 359 | issue= 11 | pages= 1143-54 | pmid=18784104 | |||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=18784104 | doi=10.1056/NEJMra0707975 }} </ref> | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 09:44, 31 May 2010
Cause / etiology
Human papillomavirus (HPV) is a risk factor for oropharyngeal cancer.[1]
Treatment
Head and Neck Cancer treatment information from the National Cancer Institute's Physician Data Query
Salivary Gland Cancer treatment information from the National Cancer Institute's Physician Data Query
Cetuximab
Cetuximab may benefit cancers by inhibiting epidermal growth factor receptor.[1]
References
- ↑ 1.0 1.1 Haddad RI, Shin DM (2008). "Recent advances in head and neck cancer.". N Engl J Med 359 (11): 1143-54. DOI:10.1056/NEJMra0707975. PMID 18784104. Research Blogging.